These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10386195)

  • 1. Antiglucocorticoid treatment of depression: double-blind ketoconazole.
    Wolkowitz OM; Reus VI; Chan T; Manfredi F; Raum W; Johnson R; Canick J
    Biol Psychiatry; 1999 Apr; 45(8):1070-4. PubMed ID: 10386195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind antiglucocorticoid treatment in schizophrenia and schizoaffective disorder: a pilot study.
    Marco EJ; Wolkowitz OM; Vinogradov S; Poole JH; Lichtmacher J; Reus VI
    World J Biol Psychiatry; 2002 Jul; 3(3):156-61. PubMed ID: 12478881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoconazole administration in hypercortisolemic depression.
    Wolkowitz OM; Reus VI; Manfredi F; Ingbar J; Brizendine L; Weingartner H
    Am J Psychiatry; 1993 May; 150(5):810-2. PubMed ID: 8480829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiglucocorticoid strategies in hypercortisolemic states.
    Wolkowitz OM; Reus VI; Manfredi F; Ingbar J; Brizendine L
    Psychopharmacol Bull; 1992; 28(3):247-51. PubMed ID: 1480727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Yu JJ; Pei LB; Zhang Y; Wen ZY; Yang JL
    J Clin Psychopharmacol; 2015 Aug; 35(4):406-10. PubMed ID: 26066335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of depression with antiglucocorticoid drugs.
    Wolkowitz OM; Reus VI
    Psychosom Med; 1999; 61(5):698-711. PubMed ID: 10511017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy.
    Murphy BE; Ghadirian AM; Dhar V
    Can J Psychiatry; 1998 Apr; 43(3):279-86. PubMed ID: 9561317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiglucocorticoid therapies in major depression: a review.
    Murphy BE
    Psychoneuroendocrinology; 1997; 22 Suppl 1():S125-32. PubMed ID: 9264159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
    Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?
    Kling MA; Coleman VH; Schulkin J
    Depress Anxiety; 2009; 26(7):641-9. PubMed ID: 19133699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind treatment of major depression with dehydroepiandrosterone.
    Wolkowitz OM; Reus VI; Keebler A; Nelson N; Friedland M; Brizendine L; Roberts E
    Am J Psychiatry; 1999 Apr; 156(4):646-9. PubMed ID: 10200751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects.
    Price LH; Cappiello A; Malison RT; McDougle CJ; Pelton GH; Schöllnhammer G; Heninger GR
    Neuropsychopharmacology; 1997 Oct; 17(4):246-57. PubMed ID: 9326749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression.
    Block T; Petrides G; Kushner H; Kalin N; Belanoff J; Schatzberg A
    J Clin Psychopharmacol; 2017 Oct; 37(5):505-511. PubMed ID: 28708736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.
    Mathew SJ; Gueorguieva R; Brandt C; Fava M; Sanacora G
    Neuropsychopharmacology; 2017 Dec; 42(13):2567-2574. PubMed ID: 28553836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment.
    Pope HG; Amiaz R; Brennan BP; Orr G; Weiser M; Kelly JF; Kanayama G; Siegel A; Hudson JI; Seidman SN
    J Clin Psychopharmacol; 2010 Apr; 30(2):126-34. PubMed ID: 20520285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.
    Anand A; Malison R; McDougle CJ; Price LH
    Biol Psychiatry; 1995 Mar; 37(5):338-40. PubMed ID: 7748987
    [No Abstract]   [Full Text] [Related]  

  • 20. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.